Janssen Pharmaceuticals has settled its legal cases with 36 states and the District of Columbia regarding promotional and marketing practices for its atypical antipsychotic prescription medication Risperdal. The company will shell out ...
Tags: atypical antipsychotic prescription medication, rispedal